Biomineralized nanomedicine for enhanced cancer therapy through in situ toxification and amplified Ca2+ overload
Authors:
- Ying PengYPYing Peng
- Peng LiuPLPeng Liu
- Jinsong DingJDJinsong Ding
- Wenhu ZhouWenhu Zhou
- 25 September 2023
- journal article
- research article
- Published by Elsevier in Chemical Engineering Journal
- Vol. 475
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Drug repurposing: progress, challenges and recommendationsNature Reviews Drug Discovery, 2018
- Combinational strategy for high-performance cancer chemotherapyBiomaterials, 2018
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4Nature, 2017
- Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome SystemCurrent Cancer Drug Targets, 2014
- Cancer drug resistance: an evolving paradigmNature Reviews Cancer, 2013
- Calcium Channels and Pumps in Cancer: Changes and ConsequencesJournal of Biological Chemistry, 2012
- Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)Drug Discovery Today, 2012
- Copper in diseases and treatments, and copper‐based anticancer strategiesMedicinal Research Reviews, 2009
- Nitric Oxide and Endoplasmic Reticulum StressArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Elevated Expression of Valosin-Containing Protein (p97) Is Associated with Poor Prognosis of Prostate CancerClinical Cancer Research, 2004